Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Zhou Luo Ou"'
Purpose: The biological axes of chemokines and chemokine receptors, such as CXCR4/CXCL12, CCR7/CCL19 (CCL21), CCR9/CCL25, and CXCR5/CXCL13, are involved in cancer growth and metastasis. This study is aimed at the potential regulatory role of atypical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b03e89457cd0056343b42952ba0aec
https://doi.org/10.1158/1078-0432.c.6517531.v1
https://doi.org/10.1158/1078-0432.c.6517531.v1
Translation on this Article from Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6573e7c071cfef2dfe5644b66f7adc5f
https://doi.org/10.1158/1078-0432.22440160
https://doi.org/10.1158/1078-0432.22440160
Autor:
Xin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, Jiong Wu, Jin-Song Lu, Gen-Hong Di, Wei Jin, Zhou-Luo Ou, Zhen-Zhou Shen, Zhi-Ming Shao
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-1 (2018)
After the publication of this work [1] an error in Fig. 1c was brought to our attention: the Western blots for PRDX6 and β-actin were similar to those shown in lanes 5-6 of Fig. 4g. To verify these findings, we have repeated this experiment and the
Externí odkaz:
https://doaj.org/article/4a0ef90c271a4c7197b097cd063f50fc
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78901 (2013)
The inhibitory effect of two chemokine decoy receptors (CDRs), DARC and D6, on breast cancer metastasis is mainly due to their ability to sequester pro-malignant chemokines. We hypothesized that genetic variants in the DARC and CCBP2 (encoding D6) ge
Externí odkaz:
https://doaj.org/article/d1ec13f1e51443f08ba084591c6927d1
Publikováno v:
Biochemical and Biophysical Research Communications. 493:1159-1167
Chemokine (C-X-C motif) ligand 17 (CXCL17) is the latest member of the chemokine family. However, its function in various cancer types is unknown. The G protein-coupled receptor 35 (GPR35) was identified as the receptor of CXCL17 and named recently a
Publikováno v:
Oncology Reports
Breast cancer is one of the most commonly diagnosed cancers worldwide and the second leading cause of cancer-related deaths among females. CCL28 (mucosa-associated epithelial chemokine, MEC), a CC subfamily chemokine, has been well studied in the pro
Autor:
Zhou Luo Ou, Wei Jin, Gen Hong Di, Jin Song Lu, Xin Zhong Chang, Jiong Wu, Yi Feng Hou, Zhen Zhou Shen, Da Qiang Li, Zhimin Shao
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 20, Iss 1, Pp 1-1 (2018)
Breast Cancer Research, Vol 20, Iss 1, Pp 1-1 (2018)
Introduction The molecular mechanisms involved in breast cancer metastasis still remain unclear to date. In our previous study, differential expression of peroxiredoxin 6 was found between the highly metastatic MDA-MB-435HM cells and their parental c
Autor:
Dong Mei Huang, You Qiong Cai, Zhou Luo Ou, Xiao Li Gu, Yong Fu Shi, Yuan Wang, Hui Juan Yu, Ting Zhang
Publikováno v:
Advanced Materials Research. :927-931
Polychlorinated biphenyls and their hydroxylated metabolites become more and more concerned for their endocrine disruption. At the presented study, experiment was designed to obtain the disruption effect of PCB101 and its hydroxylated metabolites . T
Publikováno v:
Journal of Radiation Research
Intensity-modulated radiation therapy, when used in the clinic, prolongs fraction delivery time. Here we investigated both the in vivoand in vitroradiobiological effects on the A549 cell line, including the effect of different delivery times with the
Autor:
Zhou Luo Ou, Feng Juan Lin, Xiao Li Yang, Xiao Li Gu, Zhen Zhou Shen, Zhi Ming Shao, Jian Min Luo
Publikováno v:
Breast Cancer Research and Treatment. 135:725-735
CXCL14, also known as breast and kidney-expressed chemokine, was initially identified as a chemokine highly expressed in the kidney and breast. The exact function of CXCL14 in human breast cancer is still unclear, although it has been testified to pl